Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients.

PubWeight™: 3.25‹?› | Rank: Top 1%

🔗 View Article (PMID 11748094)

Published in Circulation on December 18, 2001

Authors

C Butter1, A Auricchio, C Stellbrink, E Fleck, J Ding, Y Yu, E Huvelle, J Spinelli, Pacing Therapy for Chronic Heart Failure II Study Group

Author Affiliations

1: German Heart Institute and Charité, Campus Virchow Klinikum, Berlin, Germany.

Associated clinical trials:

Tailor-CRT: Better Application of Cardiac Resynchronization Therapy | NCT02326493

Correlating QLV Interval to Left Ventricular (LV) Lead Position in Patients Receiving Cardiac Resynchronization Therapy. (QLV) | NCT02166762

Acute Feedback on Left ventrIcular Lead Implantation Location for Cardiac Resynchronization Therapy (CCI impact) | NCT01996397

Assessment of the Axone Micro Quadripolar Lead for Enhanced Cardiac Resynchronization Therapy (ASTRAL-4LV) | NCT04463641

Articles citing this

Electrocardiographic imaging of cardiac resynchronization therapy in heart failure: observation of variable electrophysiologic responses. Heart Rhythm (2006) 2.73

High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart (2003) 2.25

Impedance cardiography as a noninvasive technique for atrioventricular interval optimization in cardiac resynchronization therapy. J Interv Card Electrophysiol (2005) 1.60

FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy. Eur J Nucl Med Mol Imaging (2006) 1.44

Variable left ventricular activation pattern in patients with heart failure and left bundle branch block. Heart (2004) 1.27

The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy. Eur Heart J (2011) 1.25

Non-contact left ventricular endocardial mapping in cardiac resynchronisation therapy. Heart (2004) 1.23

Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT. Eur J Nucl Med Mol Imaging (2010) 1.14

Haemodynamic effects of changes in atrioventricular and interventricular delay in cardiac resynchronisation therapy show a consistent pattern: analysis of shape, magnitude and relative importance of atrioventricular and interventricular delay. Heart (2006) 1.14

Usefulness of three-dimensional speckle tracking strain to quantify dyssynchrony and the site of latest mechanical activation. Am J Cardiol (2009) 1.02

The buddy wire technique: accessing lateral coronary veins while maintaining coronary sinus position. J Interv Card Electrophysiol (2005) 1.00

A computational approach to understanding the cardiac electromechanical activation sequence in the normal and failing heart, with translation to the clinical practice of CRT. Prog Biophys Mol Biol (2012) 0.91

Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy. J Interv Card Electrophysiol (2008) 0.90

Novel steerable telescoping catheter system for implantation of left ventricular pacing leads. J Interv Card Electrophysiol (2005) 0.88

Cardiac resynchronization therapy is certainly cardiac therapy, but how much resynchronization and how much atrioventricular delay optimization? Heart Fail Rev (2012) 0.87

Multimodality imaging in interventional cardiology. Nat Rev Cardiol (2012) 0.87

Method to create regional mechanical dyssynchrony maps from short-axis cine steady-state free-precession images. J Magn Reson Imaging (2013) 0.85

Long term biventricular resynchronisation therapy in advanced heart failure: effect on neurohormones. Heart (2005) 0.85

Empiric versus imaging guided left ventricular lead placement in cardiac resynchronization therapy (ImagingCRT): study protocol for a randomized controlled trial. Trials (2013) 0.85

Atrioventricular and interventricular delay optimization in cardiac resynchronization therapy: physiological principles and overview of available methods. Heart Fail Rev (2011) 0.84

Non-contrast magnetic resonance imaging for guiding left ventricular lead position in cardiac resynchronization therapy. J Interv Card Electrophysiol (2011) 0.83

Three-dimensional electroanatomic mapping of the coronary veins during cardiac resynchronization therapy implant: feasibility and possible applications. J Interv Card Electrophysiol (2014) 0.83

Imaging techniques in cardiac resynchronization therapy. Int J Cardiovasc Imaging (2007) 0.83

Changes in pulse pressure variability during cardiac resynchronization therapy in mechanically ventilated patients. Crit Care (2007) 0.83

Chest radiography is a poor predictor of left ventricular lead position in patients undergoing cardiac resynchronization therapy: comparison with multidetector computed tomography. J Interv Card Electrophysiol (2011) 0.82

The relative role of patient physiology and device optimisation in cardiac resynchronisation therapy: A computational modelling study. J Mol Cell Cardiol (2015) 0.82

Cardiac resynchronization therapy and AV optimization increase myocardial oxygen consumption, but increase cardiac function more than proportionally. Int J Cardiol (2013) 0.82

Vector selection of a quadripolar left ventricular pacing lead affects acute hemodynamic response to cardiac resynchronization therapy: a randomized cross-over trial. PLoS One (2013) 0.82

The interaction of interventricular pacing intervals and left ventricular lead position during temporary biventricular pacing evaluated by tissue Doppler imaging. Heart (2007) 0.82

[Cardiac resynchronization therapy for heart failure - from experimental pacing to evidence-based therapy]. Clin Res Cardiol (2006) 0.81

Standard chest radiograph predicts left ventricular lead location in chronic resynchronization therapy patients more accurately than intraoperative fluoroscopy. J Interv Card Electrophysiol (2012) 0.81

Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment: need for individualisation of lead localisation. Heart (2006) 0.81

Improvement in pump function with endocardial biventricular pacing increases with activation time at the left ventricular pacing site in failing canine hearts. Am J Physiol Heart Circ Physiol (2011) 0.81

"Dialing-in" cardiac resynchronization therapy: overcoming constraints of the coronary venous anatomy. J Interv Card Electrophysiol (2007) 0.81

Cardiac resynchronization therapy evaluated by myocardial scintigraphy with 99mTc-MIBI: changes in left ventricular uptake, dyssynchrony, and function. Eur J Nucl Med Mol Imaging (2009) 0.80

A systematic approach to designing reliable VV optimization methodology: assessment of internal validity of echocardiographic, electrocardiographic and haemodynamic optimization of cardiac resynchronization therapy. Int J Cardiol (2012) 0.80

Phrenic nerve stimulation in CRT patients and benefits of electronic lead repositioning: the ERACE trial. J Interv Card Electrophysiol (2013) 0.79

Optimisation of cardiac resynchronisation therapy: addressing the problem of "non-responders". Heart (2005) 0.79

Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming. World J Cardiol (2014) 0.79

How to improve outcomes with cardiac resynchronisation therapy: importance of lead positioning. Heart Fail Rev (2012) 0.79

The variable functional effects of the pacing site in normal and scarred ventricles. J Nucl Cardiol (2009) 0.78

Adverse response to cardiac resynchronisation therapy in patients with septal scar on cardiac MRI preventing a septal right ventricular lead position. J Interv Card Electrophysiol (2011) 0.78

[Effect of CRT on morbidity and mortality]. Herzschrittmacherther Elektrophysiol (2005) 0.78

Minimally invasive video-assisted thoracoscopic left ventricular epicardial lead implantation for biventricular pacing in a patient with persistent left superior vena cava. Heart Vessels (2008) 0.78

Right ventricular pacing and sensing function in high posterior septal and apical lead placement in cardiac resynchronization therapy. Indian Pacing Electrophysiol J (2012) 0.78

Influence of the atrio-ventricular delay optimization on the intra left ventricular delay in Cardiac Resynchronization Therapy. Cardiovasc Ultrasound (2006) 0.78

Long-term hemodynamic benefit of biventricular pacing depending on coronary sinus lead position. Herzschrittmacherther Elektrophysiol (2006) 0.78

Right ventricular lead adjustment in cardiac resynchronization therapy and acute hemodynamic response: a pilot study. J Interv Card Electrophysiol (2012) 0.77

British randomised controlled trial of AV and VV optimization ("BRAVO") study: rationale, design, and endpoints. BMC Cardiovasc Disord (2014) 0.77

[Effect of cardiac resynchronization therapy (CRT) on exercise tolerance, functional capacity and quality of life in patients with congestive heart failure]. Herzschrittmacherther Elektrophysiol (2005) 0.77

Baseline asynchrony, assessed circumferentially using temporal uniformity of strain, besides coincidence between site of latest mechanical activation and presumed left ventricular lead position, predicts favourable prognosis after resynchronization therapy. Int J Cardiovasc Imaging (2011) 0.77

Relationship Between Changes in Pulse Pressure and Frequency Domain Components of Heart Rate Variability During Short-Term Left Ventricular Pacing in Patients with Cardiac Resynchronization Therapy. Med Sci Monit (2016) 0.77

[Strategies to avoid complications and to solve technical problems during the implantation of CRT and CRT-D systems]. Herzschrittmacherther Elektrophysiol (2006) 0.77

Impact of oxygen uptake efficiency slope as a marker of cardiorespiratory reserve on response to cardiac resynchronization therapy. Clin Res Cardiol (2010) 0.77

[Left ventricular pacing and CRT. What CV lead fits into which vein?]. Herzschrittmacherther Elektrophysiol (2006) 0.76

Impact of left ventricular lead position on the incidence of ventricular arrhythmia and clinical outcome in patients with cardiac resynchronization therapy. J Interv Card Electrophysiol (2010) 0.76

Single-center experience of a quadripolar pacing lead for cardiac resynchronization therapy. J Interv Card Electrophysiol (2013) 0.76

Potential uses of computed tomography for management of heart failure patients with dyssynchrony. Crit Pathw Cardiol (2008) 0.75

High-density epicardial activation mapping to optimize the site for video-thoracoscopic left ventricular lead implant. J Cardiovasc Electrophysiol (2014) 0.75

Does cardiac resynchronization therapy benefit patients with right bundle branch block: left ventricular free wall pacing: seldom right for right bundle branch block. Circ Arrhythm Electrophysiol (2014) 0.75

Image-guided left ventricular lead placement in cardiac resynchronization therapy for patients with heart failure: a meta-analysis. BMC Cardiovasc Disord (2015) 0.75

Non-contact left ventricular endocardial mapping for cardiac resynchronisation therapy: a "slow conduction" towards the fast solution. Heart (2004) 0.75

Epidemiological and evolutionary characteristics of heart failure in patients with left bundle branch block - A Moroccan center-based study. J Saudi Heart Assoc (2014) 0.75

Prevalence of E/A wave fusion and A wave truncation in DDD pacemaker patients with complete AV block under nominal AV intervals. PLoS One (2015) 0.75

New generation of transvenous left ventricular leads - first experience with implantation of multipolar left ventricular leads. Exp Clin Cardiol (2011) 0.75

Pre-Implant Assessment For Optimal LV Lead Placement In CRT: ECG, ECHO, or MRI? J Atr Fibrillation (2015) 0.75

[Epidemiology and management of heart failure in a Moroccan center]. Pan Afr Med J (2016) 0.75

Analysis of lead placement optimization metrics in cardiac resynchronization therapy with computational modelling. Europace (2016) 0.75

Comparison of Echocardiographic Markers of Cardiac Dyssynchrony and Latest Left Ventricular Activation Site in Heart Failure Patients with and without Left Bundle Branch Block. J Tehran Heart Cent (2013) 0.75

A novel fluoroscopic method of measuring right-to-left interlead distance as a predictor of reverse left ventricular remodeling after cardiac resynchronization therapy. J Interv Card Electrophysiol (2013) 0.75

Successful cardiac resynchronization therapy in a 9-year-old boy with dilated cardiomyopathy. Z Kardiol (2005) 0.75

Biophysical Modeling to Determine the Optimization of Left Ventricular Pacing Site and AV/VV Delays in the Acute and Chronic Phase of Cardiac Resynchronization Therapy. J Cardiovasc Electrophysiol (2016) 0.75

[From guiding catheter to coronary sinus lead]. Herzschrittmacherther Elektrophysiol (2006) 0.75

Cardiac resynchronization: a brief synopsis part I: patient selection and results from clinical trials. J Interv Card Electrophysiol (2003) 0.75

Global electrophysiological and hemodynamic assessment of ventricular pacing employing non-contact mapping. J Interv Card Electrophysiol (2009) 0.75

[Optimal electrode placement. What to consider during implantation of a biventricular pacemaker?]. Herzschrittmacherther Elektrophysiol (2009) 0.75

Bifocal right ventricular pacing: an alternative way to achieve resynchronization when left ventricular lead insertion is unsuccessful. J Interv Card Electrophysiol (2012) 0.75

[Acute hemodynamic effects]. Herzschrittmacherther Elektrophysiol (2005) 0.75

Intra-atrial thrombosis and pulmonary embolism complicating pacemaker leads for cardiac resynchronization therapy. J Interv Card Electrophysiol (2003) 0.75

Articles by these authors

Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA. Proc Natl Acad Sci U S A (1993) 9.47

Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus. J Virol (1975) 5.99

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat Biotechnol (1999) 5.13

Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation (1999) 4.64

Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet (1995) 4.46

Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J (2001) 4.36

The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team. J Gen Intern Med (1996) 3.87

Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J Mol Biol (1994) 3.85

Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation (1999) 3.44

Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids. Proc Natl Acad Sci U S A (1999) 3.03

Human magnetic resonance imaging at 8 T. NMR Biomed (1998) 2.96

GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell (1996) 2.86

Rice transposable elements: a survey of 73,000 sequence-tagged-connectors. Genome Res (2000) 2.83

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia (2010) 2.83

Alcohol drinking and all cancer mortality: a meta-analysis. Ann Oncol (2012) 2.83

Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene (2010) 2.73

Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms. Structure (1996) 2.69

Spt16-Pob3 and the HMG protein Nhp6 combine to form the nucleosome-binding factor SPN. EMBO J (2001) 2.56

Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not. Proc Natl Acad Sci U S A (1994) 2.56

Structure of HIV-1 reverse transcriptase/DNA complex at 7 A resolution showing active site locations. Nature (1992) 2.52

Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation (2000) 2.49

Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol (2001) 2.46

Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem (1995) 2.35

Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci U S A (2000) 2.30

Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry (2006) 2.22

Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest (2001) 2.20

Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol (2000) 2.20

Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed (2006) 2.19

Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J Biol Chem (1995) 2.06

Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation (2004) 2.04

Ssn6-Tup1 interacts with class I histone deacetylases required for repression. Genes Dev (2000) 2.03

Implementation and experimental results of 4D tumor tracking using robotic couch. Med Phys (2012) 1.96

Capacitative Ca(2+) entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol (2001) 1.94

Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase. Biochemistry (1995) 1.93

Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene (2010) 1.92

Artery and vein separation using susceptibility-dependent phase in contrast-enhanced MRA. J Magn Reson Imaging (2000) 1.91

The forearm flap. Clin Plast Surg (1982) 1.90

Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome (1996) 1.90

Intraoperative planning and evaluation of permanent prostate brachytherapy: report of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys (2001) 1.89

Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol (1997) 1.88

Impact of cardiac resynchronization therapy using hemodynamically optimized pacing on left ventricular remodeling in patients with congestive heart failure and ventricular conduction disturbances. J Am Coll Cardiol (2001) 1.80

Conserved requirement for EGF-CFC genes in vertebrate left-right axis formation. Genes Dev (1999) 1.74

Epistasis analysis of suppressor mutations that allow HO expression in the absence of the yeast SW15 transcriptional activator. Genetics (1994) 1.73

Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion. Virology (1994) 1.72

Myocardial catecholamine content after heart transplantation. Circulation (1990) 1.69

The Swi5 activator recruits the Mediator complex to the HO promoter without RNA polymerase II. Genes Dev (2001) 1.68

Squamous esophageal histology and subsequent risk of squamous cell carcinoma of the esophagus. A prospective follow-up study from Linxian, China. Cancer (1994) 1.68

A novel bifunctional phospholipase c that is regulated by Galpha 12 and stimulates the Ras/mitogen-activated protein kinase pathway. J Biol Chem (2000) 1.67

Characteristics of yeasts isolated from Pacific crab meat. Appl Microbiol (1965) 1.67

Structural requirements of iron-responsive elements for binding of the protein involved in both transferrin receptor and ferritin mRNA post-transcriptional regulation. Nucleic Acids Res (1990) 1.66

Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3). Diabetologia (2008) 1.66

Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. J Mol Biol (1996) 1.65

Regulation of sodium-calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice. J Mol Cell Cardiol (2001) 1.65

Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J Immunol (1999) 1.61

Chronic continuous positive airway pressure (CPAP) reduces airway reactivity in vivo in an allergen-induced rabbit model of asthma. J Appl Physiol (1985) (2011) 1.60

Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer (2009) 1.60

Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci (2003) 1.60

Accurate in vitro end joining of a DNA double strand break with partially cohesive 3'-overhangs and 3'-phosphoglycolate termini: effect of Ku on repair fidelity. J Biol Chem (2001) 1.57

Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active site. Chem Biol (1999) 1.56

Iron regulates cytoplasmic levels of a novel iron-responsive element-binding protein without aconitase activity. J Biol Chem (1994) 1.56

Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54

Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation (2000) 1.53

Role of C5a in multiorgan failure during sepsis. J Immunol (2001) 1.53

Intracellular energetic units in red muscle cells. Biochem J (2001) 1.53

The FLUSH trial--flushing with lipiodol for unexplained (and endometriosis-related) subfertility by hysterosalpingography: a randomized trial. Hum Reprod (2004) 1.52

Design and assembly of an 8 tesla whole-body MR scanner. J Comput Assist Tomogr (1999) 1.52

Electronic phase separation at the LaAlO₃/SrTiO₃ interface. Nat Commun (2011) 1.51

The American Brachytherapy Society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int J Radiat Oncol Biol Phys (2000) 1.50

The role of expectations in patients' reports of post-operative outcomes and improvement following therapy. Med Care (1993) 1.50

Angiographical and Doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography. DEBATE study group. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur Heart J (2000) 1.49

Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens (2000) 1.49

Development and validation of a clinical index to predict survival after cardiac resynchronisation therapy. Heart (2009) 1.49

Chronic hypoxia decreases K(V) channel expression and function in pulmonary artery myocytes. Am J Physiol Lung Cell Mol Physiol (2001) 1.44

A deficiency in DNA repair and DNA-PKcs expression in the radiosensitive BALB/c mouse. Cancer Res (2000) 1.44

Inhibitory effects of low-dose polymyxin B on hemorrhage-induced endotoxin/bacterial translocation and cytokine formation in rats. J Trauma (1995) 1.44

Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics. Europace (2010) 1.43

Graves orbitopathy: correlation of CT and clinical findings. Radiology (1990) 1.42

The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur Heart J (2001) 1.42

Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins. Virus Res (1994) 1.42

Intestinal cytokine response after gut ischemia: role of gut barrier failure. Ann Surg (1999) 1.42

Differential increase in the expression of heat shock protein family members during sleep deprivation and during sleep. Neuroscience (2003) 1.41

Theoretical model for an MRI radio frequency resonator. IEEE Trans Biomed Eng (2000) 1.40

Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother (1994) 1.40

Distinct regions of the Swi5 and Ace2 transcription factors are required for specific gene activation. J Biol Chem (1999) 1.40

Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine. Psychiatr Serv (2001) 1.39

An arteriovenous fistula model of intimal hyperplasia for evaluation of a nitinol U-Clip anastomosis. Eur J Vasc Endovasc Surg (2011) 1.39

Modulation of endoplasmic reticulum calcium pump by Bcl-2. Oncogene (1998) 1.39

Safety profile of a divided dose of propranolol for heart rate in children with infantile haemangioma during 16 weeks of treatment. Br J Dermatol (2014) 1.38

Signal-to-noise ratio gain in neuronal systems. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 1.38

[Long-term outcome after coronary emergency intervention]. Dtsch Med Wochenschr (2000) 1.38

A modified method of labia minora reduction: the de-epithelialised reduction of the central and posterior labia minora. J Plast Reconstr Aesthet Surg (2012) 1.38

USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation. Cell Death Differ (2011) 1.38

Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation (1998) 1.37

Sds3 (suppressor of defective silencing 3) is an integral component of the yeast Sin3[middle dot]Rpd3 histone deacetylase complex and is required for histone deacetylase activity. J Biol Chem (2000) 1.37

The optimal management of cardioversion of atrial fibrillation or flutter: still a 'stunning' problem. Eur Heart J (2000) 1.37

Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents. J Magn Reson Imaging (2001) 1.37

Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J Neurol Sci (1998) 1.37